The interleukin 23 receptor gene in multiple sclerosis: A case-control study

24Citations
Citations of this article
18Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Variants of the gene coding for interleukin 23 receptor (IL23R) have been confirmed to be associated with inflammatory bowel disease (IBD). Based on similarities in the autoimmune features of IBD and multiple sclerosis (MS), we selected this gene for analysis as a candidate gene in MS. We tested 32 single nucleotide polymorphisms tagging all parts of the gene including 10 markers previously studied in IBD for association with MS. The study population consisted of 1114 MS patients and 1235 controls of Scandinavian origin. None of the tests showed more than very modest differences between patients and controls. Haplotypes were constructed and were also similarly distributed in patients and controls. We conclude that it is unlikely that the IL23R gene confers any significant risk for MS. © 2007 Elsevier B.V. All rights reserved.

Cite

CITATION STYLE

APA

Roos, I. M., Kockum, I., & Hillert, J. (2008). The interleukin 23 receptor gene in multiple sclerosis: A case-control study. Journal of Neuroimmunology, 194(1–2), 173–180. https://doi.org/10.1016/j.jneuroim.2007.11.011

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free